Synergis Adept Ranked #1 in Usability, Setup, Support, and Relationship in G2 Winter 2022 Reports
Synergis Software, a global leader in document management and workflow solutions, today announced that its flagship product, Adept, has earned 30 #1 rankings in G2’s Winter 2022 Grid Reports. The first-place rankings extend across G2’s Enterprise Content Management, Product Data Management, and Construction Drawing Management categories.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220111005239/en/
Synergis Adept Ranked #1 in Usability, Setup, Support, and Relationship in G2 Winter 2022 Reports (Graphic: Business Wire)
The G2 reports, based on independently validated reviews, highlight key advantages that matter most to customers, including “best usability”, “easiest setup”, “fastest implementation”, “best support”, and “best relationship”.
Adept retains its position at the very top of G2’s Implementation Index, Usability Index, and Relationship Index for Product Data Management (PDM) for the sixth consecutive quarter.
“As a software developer and a trusted partner, we take G2’s reports to heart. Understanding how our customers experience our software and the partnership they have with us is a critical guidepost for our business”, said Scott Lamond, vice president of marketing at Synergis Software. “Our customers’ voices enliven our product direction and reflect how well we’re serving them.”
The Winter 2022 Grid® Reports are based on G2’s unique algorithm, which calculates customer satisfaction and market presence scores in real-time. Results from user reviews and data aggregated from online sources and social networks, Adept earned #1 placements in the following categories:
Product Data Management (PDM)
#1 Usability Index
#1 Implementation Index
#1 Relationship Index
#1 Best Meets Requirements, Mid-Market
#1 Implementation Time
#1 Implementation Time, Mid-Market
#1 Ease of Setup, Mid-Market
#1 Ease of Admin
#1 Ease of Admin, Mid-Market
#1 Ease of Doing Business With, Mid-Market
#1 Most Likely to Recommend
#1 Most Likely to Recommend, Mid-Market
#1 Net Promoter Score
#1 Net Promoter Score, Mid-Market
#1 Quality of Support
#1 Quality of Support, Mid-Market
#1 User Adoption, Mid-Market
#1 in Version Control
Construction Drawing Management
#1 Document Management Features, Small Business
#1 Ease of Doing Business With
#1 Ease of Doing Business With, Small Business
#1 Ease of Setup, Mid-Market
#1 Best Meets Requirements, Small Business
#1 Net Promoter Score
#1 Net Promoter Score, Small Business
#1 Quality of Support
#1 Quality of Support, Mid-Market
#1 Quality of Support, Small Business
Enterprise Content Management (ECM)
#1 Ease of Doing Business With, Mid-Market
#1 Most Likely to Recommend, Mid-Market
Adept also ranks in the top three in Enterprise Content Management for Search, Metadata, Version Control, Likelihood to Recommend, Net Promoter Score, and Relationship Index, Mid-Market.
Synergis was awarded the additional, “Users Love Us” badge, which honors software solutions that are consistently reviewed and highly rated by their users.
Review Feedback from Verified Users on G2 Crowd
Here are some of the quotes from Synergis’ customers in verified reviews on G2:
- “Data is the cornerstone of any business today and not securing it is a huge risk. If you want to do it right and do it well, the Adept platform is the gold-standard."
Ryan Mongeau, Director of Technology
Space Age Electronics
- “I've been in IT for 25 years. I've chatted with thousands of vendors, worked with hundreds of consultants, administered dozens of enterprise software platforms, and the gang at Synergis is my favorite by far. I always—seriously, always —feel like a priority!”
Blake Donley, Sr. IT Analyst
Great River Energy
- "We use Adept to organize construction documents for almost 200 buildings, 6 campuses and nearly 1 billion dollars in active construction. Using Adept, our maintenance technicians and project teams can quickly locate and share the information they need to be successful.”
Chad Thome, Sr IT Business Analyst
University of Houston
- "We manage entire plant documentation for a process plant running 24/7/365. Adept gives us access to current plant conditions, vendor documentation, installation and operating manuals—all available by searching the equipment tag number."
Paul Opiela, Document Control Coordinator
Aux Sable
Read more about Synergis Adept in G2 Winter 2022 Grid Reports here.
Learn how Adept stacks up to the competition in the PDM market here.
About Synergis Software
Synergis Software is a global leader in document management and workflow solutions and is the creator of Synergis Adept software. Adept serves more than 120,000 users across dozens of industries providing fast, centralized access to design and business documents in a secure, collaborative environment. Adept Integrator connects your enterprise applications so your data and business processes flow seamlessly across your entire IT infrastructure.
Named the customer service leader in the global engineering information management market by Frost & Sullivan and ranked in the Top 5 globally by Helpdesk International for three consecutive years, our commitment to clients is unwavering.
Founded in 1985, Synergis Technologies, LLC is headquartered in Bucks County, PA and is privately owned and funded. For more information, visit SynergisSoftware.com.
Adept has been battle tested by engineers for over 30 years with customers such as Dow Chemical, Con Edison, General Mills, Merck, NASA, and Nucor Steel.
About G2 Crowd
G2 is the world’s largest tech marketplace where businesses can discover, review, and manage the technology they need to reach their potential. Today, more than 3M people visit G2 to read and write authentic reviews about thousands of software products and professional services. G2 has published over 1,000,000 reviews and over 5 million visitors are helping millions of businesses make better buying decisions — and reach their full potential.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220111005239/en/
Contact information
Scott Lamond
Vice President of Marketing
Email: scott.lamond@synergis.com
Phone: 215-302-3006
About Business Wire
Business WireSubscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
HCLTech Reports FY24 Revenue of $13.3 Billion, up 5.4% YoY26.4.2024 22:06:00 CEST | Press release
HCLTech, a leading global technology company, today reported financial results for the fourth quarter and the full year ended March 31, 2024. The company reported full year revenue of $13.3 billion, up 5.4% YoY. Digital Services revenue grew by 5.3% (CC) and now contributes to 37.3% of IT Services revenue. HCLSoftware’s Annual Recurring Revenue came in at $1.02 billion. During FY24, the company won 73 large deals – 36 in Services and 37 in Software - that translated into TCV (new deal wins) of $9.76 billion, up 10% YoY. For the quarter, revenue came in at $3.43 billion, up 6% YoY. HCLTech won 21 large deals – 13 in Services and eight in Software, with a TCV of $2.29 billion during the quarter. In terms of geographies, Americas was the fastest growing region with 6.8% YoY (CC) growth followed by Europe, which grew by 5.5% YoY (CC). Industry vertical growth was led by Financial Services and Telecommunications, Media, Publishing & Entertainment. While Financial Services grew at 12.1% YoY
Kinaxis Positioned Highest on Ability to Execute in the Gartner® Magic Quadrant™ for Supply Chain Planning Solutions26.4.2024 18:03:00 CEST | Press release
Kinaxis® Inc. (TSX:KXS), a global leader in end-to-end supply chain orchestration, today announced it has been named a Leader in the 2024 Gartner® Magic Quadrant™ for Supply Chain Planning Solutions. Of the 20 vendors evaluated, Gartner positioned Kinaxis highest on Ability to Execute, marking the company’s 10th consecutive Leaders Quadrant within the report, a complimentary copy of which can be downloaded here. Kinaxis attributes its position to its patented concurrency approach and a proven track record of delivering innovative solutions against the foundation of its leading vision through the use of advanced technology such as AI, ML, and an intuitive user experience. Bolstered by a rich ecosystem of third-party implementation partners, Kinaxis continues to demonstrate that regardless of a customer’s industry, size, or maturity level, the company can be counted on to seamlessly orchestrate supply chain networks end-to-end from strategic planning to last-mile delivery. The recognitio
Vertex Announces European Commission Approval for KALYDECO ® to Treat Infants With Cystic Fibrosis Ages 1 Month and Older26.4.2024 17:43:00 CEST | Press release
Vertex Pharmaceuticals (Nasdaq: VRTX) today announced that the European Commission has granted approval for the label expansion of KALYDECO® (ivacaftor) for the treatment of infants down to 1 month of age with cystic fibrosis (CF) who have one of the following mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene: R117H, G551D, G1244E, G1349D, G178R, G551S, S1251N, S1255P, S549N or S549R. “Today’s approval is an important milestone for the cystic fibrosis community. Treating CF early in life can potentially slow the progression of the disease, which is why it is so important to start treatment from a very young age,” said Carmen Bozic, M.D., Executive Vice President, Global Medicines Development and Medical Affairs, and Chief Medical Officer, Vertex. As a result of existing access agreements in Austria, Czech Republic, Denmark, Ireland, Norway, Sweden, and The Netherlands, eligible patients will have access to the expanded indication of KALYDECO® (ivacaftor)
Suzano 2023 annual report on Form 20-F26.4.2024 17:22:00 CEST | Press release
Suzano S.A. (B3: SUZB3 | NYSE: SUZ) informs that its 2023 Annual Report on Form 20-F was filed today with the U.S. Securities and Exchange Commission. Holders of the Company’s equity securities can receive hard copies of the Annual Report, including its audited financial statements, without charge by request directed to: ri@suzano.com.br. This document is also available on Suzano’s website (http://ir.suzano.com.br/). For further information, please contact our Investor Relations Department: Phone: (+55 11) 3503-9330 E-mail: ri@suzano.com.br View source version on businesswire.com: https://www.businesswire.com/news/home/20240426289818/en/Contact information Hawthorn Advisors suzano@hawthornadvisors.com
Takeda Receives Positive CHMP Opinion for Fruquintinib in Previously Treated Metastatic Colorectal Cancer26.4.2024 14:30:00 CEST | Press release
Takeda (TSE:4502/NYSE:TAK) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of fruquintinib, a selective inhibitor of vascular endothelial growth factor receptors (VEGFR) -1, -2 and -3 for the treatment of adult patients with previously treated metastatic colorectal cancer (mCRC). The European Commission (EC) will consider the CHMP positive opinion when determining the potential marketing authorization for fruquintinib for mCRC throughout the European Union (EU), Norway, Liechtenstein and Iceland. If approved, fruquintinib will be the first and only selective inhibitor of all three VEGF receptors approved in the EU for previously treated mCRC.1,2 “People living with metastatic colorectal cancer in the European Union currently have limited treatment options, which can lead to poor outcomes. With this positive opinion for fruquintinib, we are one step closer to potentially offering patients a new
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom